Lipid Controls
Medchemexpress LLC Dspe-peg2000-cys-srnlidc (disulfide bridge cys1-cys8) | 95.2% | 2000 Da (average) | 10 MG
DSPE-PEG2000-Cys-SRNLIDC is a lipid-PEG conjugate that links a DSPE lipid to a cyclic SRNLIDC peptide through a PEG2000 spacer containing a disulfide bridge (Cys1-Cys8). It is provided for research use to functionalize lipid nanoparticles or liposomes for targeting and to enable disulfide-triggered intracellular release. PEGylation improves colloidal stability and compatibility with aqueous formulations.
- Enables surface functionalization of lipid nanoparticles.
- Provides disulfide-mediated intracellular release of linked cargo.
- PEG2000 spacer enhances colloidal stability and circulation.
- Supplied with high reported purity for research applications.
- Soluble in DMSO for stock solution preparation.
- Recommended storage at -20°C to preserve integrity.
Cayman Chemical 1 3DIoctnoyl2Oleoyl Glyce 10mg
A triacylglycerol; reduces total cholesterol levels in both the plasma and aorta in a diet-induced hamster model of hypercholesterolemia
![eMolecules Broadpharm / BP Lipid 134 / 50mg / 672542526 / BP-26391 / / / [null] / 696.155 / C43H85NO5](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502480222.JPG-250.jpg)
eMolecules Broadpharm / BP Lipid 134 / 50mg / 672542526 / BP-26391 / / / [null] / 696.155 / C43H85NO5
Broadpharm / BP Lipid 134 / 50mg / 672542526 / BP-26391 / / / [null] / 696.155 / C43H85NO5
Avanti Polar Lipids 1-oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt), 326589-90-6, MFCD00674368, 5mg
Molecular Formula: C24H45NO9PNa, Formula Weight: 545.579, Purity >99% LPS; may contain up to 10% of the 2-LPS isomer.
Cayman Chemical 1 3DIstearoyl2oloyl Glyce 10mg
A triacylglycerol; has been found in Kpangnana, Chinese tallow, and cocoa butters; increases the phagocytic function of reticulo-endothelial cells in mice at 5 and 10 mg per animal
Cayman Chemical 1 3DIoctnoyl2Oleoyl Glyce 1mg
A triacylglycerol; reduces total cholesterol levels in both the plasma and aorta in a diet-induced hamster model of hypercholesterolemia
Medchemexpress LLC Fluorescent DOTAP (NBD-DOTAP) | 1010076-97-7 | 96.0% | 710.34 g·mol⁻¹ | C36H60ClN5O7 | 5 MG
Fluorescent DOTAP (NBD-DOTAP) is an NBD-labeled cationic lipid used for nucleic acid and protein delivery, membrane labeling, and nanocarrier tracking. The NBD fluorophore provides visible-range excitation and emission suitable for imaging and formulation research. The compound is supplied as a solid and should be protected from light and stored under the temperature conditions recommended for solvent or bulk storage.
- NBD-labeled cationic lipid for delivery and imaging.
- Suitable for nucleic acid and protein transfection studies.
- Visible-range fluorescence (approx. 463/536 nm) for tracking.
- High purity for research applications.
- Stable solid form; protect from light and store under recommended conditions.
Medchemexpress LLC 1,2-dioleoyloxy-3-(dimethylamino)propane | 127512-29-2 | MFCD01321074 | >98.0% | C41H77NO4 | 10MG
DODAP is an ionizable cationic lipid used to formulate liposomes and lipid nanoparticles for encapsulating and delivering nucleic acids such as siRNA and oligonucleotides. It is neutral at physiological pH and becomes protonated in acidic endosomal environments, aiding release of cargo and improving transfection efficiency.
- Ionizable cationic lipid for nucleic acid encapsulation
- pKa around 5.6 enabling endosomal protonation and cargo release
- High purity suitable for research applications (>98%)
- Compatible with common organic solvents for formulation work
- Used in liposome and LNP formulations to enhance delivery efficiency
![eMolecules Broadpharm / DLin-DMA / 25mg / 779524115 / BP-29593 / / 871258-12-7 / [null] / 616.072 / C41H77NO2](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502464019.JPG-250.jpg)
eMolecules Broadpharm / DLin-DMA / 25mg / 779524115 / BP-29593 / / 871258-12-7 / [null] / 616.072 / C41H77NO2
Broadpharm / DLin-DMA / 25mg / 779524115 / BP-29593 / / 871258-12-7 / [null] / 616.072 / C41H77NO2
Cayman Chemical DLIn-MC2-DMA 1mg
An ionizable cationic lipid; has been used in the formation of LNPs; LNPs containing DLin-MC2-DMA and encapsulating siRNA targeting mRNA encoding FVII reduce hepatic levels of FVII in mice (ED50 = 0.6 mg/kg)
Apexbio Technology LLC DMG-PEG2000-N3 100mg
DMG-PEG2000-N3 is a PEGylated lipid derivative utilized for the functionalization of lipid-based drug delivery systems It consists of 1 2-dimyristoyl-sn-glycerol (DMG) polyethylene glycol (PEG 2000 Da) and a terminal azide group (N3) The azide functional group enables selective conjugation via copper-catalyzed azide-alkyne cycloaddition (CuAAC or click chemistry) allowing controlled attachment of biomolecules small-molecule drugs fluorescent probes or targeting ligands onto lipid bilayers DMG-PEG2000-N3 is widely applied in the development of liposomal or nanoparticle formulations for targeted drug delivery and imaging in biomedical research
Medchemexpress LLC Pentanoic acid, 5-(dimethylamino)-, (10Z,13Z)-1-(9Z,12Z)-9,12-octadecadien-1-yl ester | 1226909-66-5 | 98.0% | 656.12 | C44H81NO2 | 10 MG
DLin-M-C4-DMA is a cationic ionizable lipid used to formulate lipid nanoparticles for delivery of nucleic acids, including siRNA and mRNA. It is supplied for research use and is characterized by a long aliphatic structure that enables incorporation into lipid-based delivery systems. Handle and store under recommended cold-chain conditions to preserve integrity.
- Cationic lipid for delivery of nucleic acids (siRNA, mRNA).
- Suitable for formulation of lipid nanoparticles and transfection reagents.
- Molecular formula C44H81NO2 and molecular weight 656.12.
- Purity (NMR) 98.0%.
- Available in small mg quantities and as 10 mM solutions in DMSO.
- Storage: pure form -20°C (long term) and 4°C (short term); solutions -80°C recommended.
- Intended for research use only; not for clinical or therapeutic use.
Cayman Chemical 25-hydroxy Cholesterol 100mg
An oxysterol; suppresses endogenous cholesterol synthesis by binding INSIG proteins and preventing SREBPs from being transported to the Golgi; inhibits IgA class switching induced by LPS and various cytokines in B cells (IC50 = ~50 nM); inhibits replication of SARS-CoV-2 in Vero cells (EC50 = 3.675 µM) and reduces increases in viral protein production in infected Vero cells when used prior to infection; reduces viral RNA loads in the lung and trachea in a mouse model of SARS-CoV-2 infection at 100 mg/kg per day; serum levels are increased in patients with SARS-CoV-2.
